平扫CT机会性筛查遗传性血色病:确定最佳肝脏衰减阈值
研究在3357例无症状成人平扫CT中评估不同肝脏衰减阈值对遗传性血色病的机会性筛查阳性率,并以12例HFE C282Y纯合子患者评估敏感度;75 HU阈值敏感度83.3%、筛查阳性率1.2%,作者认为≥75 HU应触发铁过载实验室检查。
要点
- 平扫CT肝脏衰减≥75 HU时遗传性血色病敏感度83.3%(10/12),筛查阳性率1.2%(39/3357)。
- 65 HU、70 HU、75 HU阈值敏感度均为83.3%(10/12),80 HU降至50.0%(6/12)。
- 遗传性血色病组肝脏衰减78.7±13.1 HU,显著高于筛查成人组59.4±12.7 HU(p<0.001)。
核心结论
- 平扫CT肝脏衰减阈值75 HU对遗传性血色病敏感(83.3%),同时保持可接受的低筛查阳性率(1.2%);平扫CT不明原因肝脏衰减≥75 HU应触发铁过载的实验室检查,早期放血治疗可限制或预防血色病患者器官损害。
研究设计与样本
- 在3357例连续成人(平均年龄57.0岁、无肝病症状、接受结直肠癌筛查)的平扫CT上采用标准ROI放置法测量肝脏衰减(HU),评估不同阈值的筛查阳性率;另在12例HFE C282Y纯合子遗传性血色病患者(平均年龄48.3岁)中测量平扫肝脏CT衰减以评估敏感度;所有扫描均为120 kV。
诊断标准与关键数值
- 筛查成人组平均肝脏衰减59.4±12.7 HU,遗传性血色病组78.7±13.1 HU(范围59-105 HU),两组差异p<0.001;筛查阳性率在65 HU为30.6%(n=1028)、70 HU为8.2%(n=275)、75 HU为1.2%(n=39)、80 HU为0.2%(n=7);对应敏感度在65、70、75 HU均为83.3%(10/12),80 HU为50.0%(6/12)。
临床应用与阅片要点
- 作者认为平扫CT不明原因肝脏衰减≥75 HU应触发铁过载的实验室检查;早期放血治疗可限制或预防血色病患者器官损害。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study was to assess whether a specific liver attenuation threshold for unenhanced CT allows both sensitive opportunistic detection of unsuspected hereditary hemochromatosis and low overall screening test-positive rates.
MATERIALS AND METHODS: We used a standard ROI placement method on unenhanced CT studies of 3357 consecutive adults (mean age, 57.0 years) with no symptoms of liver disease who underwent colorectal screening. Hepatic attenuation (in HU) was measured to assess test-positive rates at various liver attenuation thresholds. To assess sensitivity, unenhanced hepatic CT attenuation was also measured in 12 patients with hereditary hemochromatosis (mean age, 48.3 years), who were homozygous for the HFE C282Y mutation. All scans were obtained at 120 kV. Serum ferritin levels were recorded for the hereditary hemochromatosis cohort.
RESULTS: Mean liver attenuation ± SD among screened adults was 59.4 ± 12.7 HU, compared with 78.7 ± 13.1 HU (range, 59-105 HU) in the hereditary hemochromatosis cohort (p < 0.001). Screening test-positive rates were 30.6% (n = 1028) at 65 HU, 8.2% (n = 275) at 70 HU, 1.2% (n = 39) at 75 HU, and 0.2% (n = 7) at 80 HU. Corresponding sensitivities for hereditary hemochromatosis at these thresholds were 83.3% (10/12) at 65, 70, and 75 HU; and 50.0% (6/12) at 80 HU. Serum ferritin levels were elevated in all patients with hereditary hemochromatosis (mean, 1678 ng/mL; range, 477-3991 ng/mL).
CONCLUSION: An unenhanced CT liver attenuation threshold of 75 HU was sensitive (83.3%) for hereditary hemochromatosis while maintaining an acceptably low screening test-positive rate (1.2%). An unexplained liver attenuation of 75 HU or more on unenhanced CT should trigger appropriate laboratory investigation for iron overload; early intervention with phlebotomy can limit or prevent organ damage in patients with hemochromatosis.
引用
- Lawrence EM, Pooler BD, Pickhardt PJ, et al. Opportunistic Screening for Hereditary Hemochromatosis With Unenhanced CT: Determination of an Optimal Liver Attenuation Threshold. AJR Am J Roentgenol. 2018. PMID: 30300001. doi:10.2214/AJR.18.19690
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。